REGENERON’S VEGF TRAP DEMONSTRATES POSITIVE PRELIMINARY RESULTS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION Phase 1 Preliminary Results to be Presented at the Angiogenesis 2006 Meeting sponsored by Bascom Palmer Eye Institute
Friday, February 3, 2006 BiopharmaWatch Research 1 min read
Key Takeaway: REGENERON’S VEGF TRAP DEMONSTRATES POSITIVE PRELIMINARY RESULTS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION Phase 1 Preliminary Results to be Presented at the Angiogenesis 2006 Meeting sponsored by Bascom Palmer Eye Institute
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
2.6%
average across 15 past catalysts
Lead asset
VEGF Trap-Eye
Phase 1 · Diabetic Macular Edema
Full Press Release Details
REGENERON’S VEGF TRAP DEMONSTRATES POSITIVE PRELIMINARY RESULTS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION Phase 1 Preliminary Results to be Presented at the Angiogenesis 2006 Meeting sponsored by Bascom Palmer Eye Institute.